Peter Anastasiou serves as Capsida’s Chief Executive Officer. He has decades of experience managing diverse organizations and leading them to achieve common goals. Before Capsida, Mr. Anastasiou served as an Executive Vice President and a member of the executive committee at Lundbeck, reporting to the CEO. As President of Lundbeck’s U.S. and Canadian business operations, Mr. Anastasiou led as many as 1,200 employees and achieved net revenues of $1.5 billion, playing a pivotal role in developing and launching multiple products and building the company’s cross-functional capabilities. Prior to Lundbeck, he held management roles at Neuronetics, Inc., Bristol-Meyers Squibb Company, and Eli Lilly and Company. Mr. Anastasiou served on the Board of PhRMA for more than four years and currently serves on the global advisory board for the Healthcare Businesswomen’s Association and was named the 2019 HBA Honorable Mentor.

He holds an M.B.A. from the Kelley School of Business at Indiana University and a B.A. in economics and management from Albion College.